Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Xia Dou, Lingling Liu, Xuejun Zhu, Weijing Wen, Chunya Ni, Yi Zhao, Zhixin He, Hongchun Li, Qiuning Sun, Qinping Yang, Xinfen Sun & Yifeng Guo. (2023) Safety and efficacy of Pimecrolimus in atopic dermatitis among Chinese infants: a sub-group analysis of a five-year open-label study. Journal of Dermatological Treatment 34:1.
Read now
Read now
Mareike Witte, Laura Krause, Detlef Zillikens & Iakov Shimanovich. (2019) Black tea dressings – a rapidly effective treatment for facial dermatitis. Journal of Dermatological Treatment 30:8, pages 785-789.
Read now
Read now
Brent L. Cao. (2018) Challenges in assessing rare risks associated with topical calcineurin inhibitors for the treatment of eczema. Journal of Dermatological Treatment 29:8, pages 825-825.
Read now
Read now
Articles from other publishers (16)
Hao-Hsin Huang, Dereck Shen, Tom C. Chan, Yung-Tsu Cho, Chao-Hsiun Tang & Chia-Yu Chu. (2023) Association Between the Use of Topical Calcineurin Inhibitors and the Risk of Cancer Among Patients with Atopic Dermatitis: A Nationwide, Population-Based, Retrospective Cohort Study. American Journal of Clinical Dermatology.
Crossref
Crossref
Niveditha Devasenapathy, Alexandro Chu, Melanie Wong, Archita Srivastava, Renata Ceccacci, Clement Lin, Margaret MacDonald, Aaron Wen, Jeremy Steen, Mitchell Levine, Lonnie Pyne, Lynda Schneider, Derek K Chu, Rachel Netahe Asiniwasis, Mark Boguniewicz, Renata Ceccacci, Lina Chen, Alexandro Chu, Derek K Chu, Anna De Benedetto, Niveditha Devasenapathy, Winfred T Frazier, Matthew Greenhawt, Joey Huynh, Elaine Kim, Jennifer LeBovidge, Mitchell Levine, Clement Lin, Mary Laura Lind, Peter A Lio, Margaret MacDonald, Stephen A Martin, Monica O'Brien, Peck Y Ong, Lonnie Pyne, Lynda Schneider, Jonathan I Silverberg, Jonathan M Spergel, Archita Srivastava, Jeremy Steen, Julie Wang, Aaron Wen & Melanie Wong. (2023) Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis. The Lancet Child & Adolescent Health 7:1, pages 13-25.
Crossref
Crossref
Yun Zhu, Yirong Teng, Shuangyan Xu, Yinde Xu, Boheng Zhu, Weimin Yan & Jie Liu. (2022) Eczema as a protective factor for brain cancer: a meta-analysis. BMC Cancer 22:1.
Crossref
Crossref
Po‐Chien Wu, I‐Hsin Huang, Che‐Wei Liu & Yu‐Chen Huang. (2021) Topische Calcineurininhibitoren und das Risiko für Lymphome: eine systematische Übersicht und Metaanalyse. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 19:9, pages 1265-1270.
Crossref
Crossref
Po‐Chien Wu, I‐Hsin Huang, Che‐Wei Liu & Yu‐Chen Huang. (2021) Topical calcineurin inhibitors and risk of lymphoma: a systematic review and meta‐analysis. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 19:9, pages 1265-1269.
Crossref
Crossref
Eduardo Liberato da Silva, Taiane Berguemaier de Lima, Pantelis Varvaki Rados & Fernanda Visioli. (2021) Efficacy of topical non-steroidal immunomodulators in the treatment of oral lichen planus: a systematic review and meta-analysis. Clinical Oral Investigations 25:9, pages 5149-5169.
Crossref
Crossref
Ori Finfter, Batia Avni, Sigal Grisariu, Yaron Haviv, Chen Nadler, Ori Rimon & Yehuda Zadik. (2021) Photobiomodulation (low-level laser) therapy for immediate pain relief of persistent oral ulcers in chronic graft-versus-host disease. Supportive Care in Cancer 29:8, pages 4529-4534.
Crossref
Crossref
T. Luger, A.S. Paller, A.D. Irvine, R. Sidbury, L.F. Eichenfield, T. Werfel & T. Bieber. (2021) Topical therapy of atopic dermatitis with a focus on pimecrolimus. Journal of the European Academy of Dermatology and Venereology 35:7, pages 1505-1518.
Crossref
Crossref
Megan Lam, Jie Wei Zhu, Mina Tadrous & Aaron M. Drucker. (2021) Association Between Topical Calcineurin Inhibitor Use and Risk of Cancer, Including Lymphoma, Keratinocyte Carcinoma, and Melanoma. JAMA Dermatology 157:5, pages 549.
Crossref
Crossref
David Luk, Kam Lun Ellis Hon, Maria Victoria C. Dizon, Kin-Fon Leong, Yong-Kwang Tay, Mark Jean-Aan Koh, Nisha Suyien Chandran, Siriwan Wananukul, Susheera Chatproedprai & Thomas Luger. (2020) Practical Recommendations for the Topical Treatment of Atopic Dermatitis in South and East Asia. Dermatology and Therapy 11:1, pages 275-291.
Crossref
Crossref
Vanessa Lin, Raahi Patel, Alexis Wirtz, Deepika Mannem, Ryan Ottwell, Wade Arthur, Courtney Cook, Hannah Howard, Drew Wright, Micah Hartwell & Matt Vassar. (2021) Evaluation of Spin in the Abstracts of Systematic Reviews and Meta-Analyses of Atopic Dermatitis Treatments and Interventions. Dermatology 237:4, pages 496-505.
Crossref
Crossref
Maryam M. Asgari, Ai-Lin Tsai, Lyndsay Avalos, Monica Sokil & Charles P. QuesenberryJrJr. (2020) Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis. JAMA Dermatology 156:10, pages 1066.
Crossref
Crossref
Aaron M. Drucker & Mina Tadrous. (2020) Topical Calcineurin Inhibitors and Skin Cancer—Another Piece of the Puzzle. JAMA Dermatology 156:10, pages 1053.
Crossref
Crossref
Amanda Ciccolini, Shannon French, Mark Tenn & Anne K. Ellis. 2018. Update in Pediatrics. Update in Pediatrics
39
59
.
Stephen M. Bauer. (2017) Atopic Eczema: Genetic Associations and Potential Links to Developmental Exposures. International Journal of Toxicology 36:3, pages 187-198.
Crossref
Crossref
. (2017) Tacrolimus. Reactions Weekly 1649:1, pages 232-232.
Crossref
Crossref